2022 Vol.40, N°1 - Table of contents
January 2022
Editorial
CER15469
2022,40,1
Pg. 0001-0003
Free to view
Clinical and Experimental Rheumatology turns 40: serving the rheumatology community between tradition and innovation
S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/tj864s
S. Bombardieri
DOI: https://doi.org/10.55563/clinexprheumatol/tj864s
One year in review
CER15480
2022,40,1
Pg. 0004-0014
Free to view
One year in review 2022: systemic lupus erythematosus
D. Zucchi, E. Elefante, D. Schilirò, V. Signorini, F. Trentin, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/nolysy
D. Zucchi, E. Elefante, D. Schilirò, V. Signorini, F. Trentin, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/nolysy
Full Papers
CER14090
2022,40,1
Pg. 0015-0023
Free to view
Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis
T. Eviatar, D. Zisman, O. Gendelman, T. Reitblat, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
DOI: https://doi.org/10.55563/clinexprheumatol/1sx5yk
T. Eviatar, D. Zisman, O. Gendelman, T. Reitblat, A. Balbir-Gurman, T. Mashiach, R. Almog, O. Elkayam
DOI: https://doi.org/10.55563/clinexprheumatol/1sx5yk
CER13991
2022,40,1
Pg. 0024-0032
TNF-α inhibitors reduce inflammation-induced concentric remodelling, but not diastolic dysfunction in collagen-induced arthritis
R. Le Roux, L. Mokotedi, S. Fourie, A. Manilall, S. Gunter, A.M. Millen
DOI: https://doi.org/10.55563/clinexprheumatol/l4nnv0
R. Le Roux, L. Mokotedi, S. Fourie, A. Manilall, S. Gunter, A.M. Millen
DOI: https://doi.org/10.55563/clinexprheumatol/l4nnv0
CER14069
2022,40,1
Pg. 0033-0038
Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice
G. Ligtenberg, S. Arends, C.A. Stegeman, K. De Leeuw
DOI: https://doi.org/10.55563/clinexprheumatol/c58c39
G. Ligtenberg, S. Arends, C.A. Stegeman, K. De Leeuw
DOI: https://doi.org/10.55563/clinexprheumatol/c58c39
CER14084
2022,40,1
Pg. 0039-0043
Free to view
Usage of drugs for cardiovascular diseases is increased in systemic lupus erythematosus (SLE) patients already before diagnosis of SLE
P. Elfving, H. Kautiainen, L.J. Virta, O. Kaipiainen-Seppänen, K. Puolakka
DOI: https://doi.org/10.55563/clinexprheumatol/n3z44y
P. Elfving, H. Kautiainen, L.J. Virta, O. Kaipiainen-Seppänen, K. Puolakka
DOI: https://doi.org/10.55563/clinexprheumatol/n3z44y
CER14016
2022,40,1
Pg. 0044-0048
Disease activity at the entheses and joints are correlated in psoriatic arthritis when explored with ultrasound
G. Ayan, I. Tinazzi, S. Bakirci, U. Gazel, D. Solmaz, U. Kalyoncu, S.Z. Aydin
DOI: https://doi.org/10.55563/clinexprheumatol/frrq75
G. Ayan, I. Tinazzi, S. Bakirci, U. Gazel, D. Solmaz, U. Kalyoncu, S.Z. Aydin
DOI: https://doi.org/10.55563/clinexprheumatol/frrq75
CER14315
2022,40,1
Pg. 0049-0055
Free to view
Myeloid neoplasms and autoimmune diseases: markers of association
S. Galimberti, C. Baldini, C. Baratè, M. Fornili, S. Balducci, F. Ricci, F. Ferro, E. Elefante, A. Di Paolo, L. Baglietto, V. Donati, M. Petrini
DOI: https://doi.org/10.55563/clinexprheumatol/ddxmp9
S. Galimberti, C. Baldini, C. Baratè, M. Fornili, S. Balducci, F. Ricci, F. Ferro, E. Elefante, A. Di Paolo, L. Baglietto, V. Donati, M. Petrini
DOI: https://doi.org/10.55563/clinexprheumatol/ddxmp9
CER14171
2022,40,1
Pg. 0056-0063
Modulation of miR-548m encoded by X chromosome on the PTEN pathway in systemic lupus erythematosus
X. Yang, L. Shi, X. Zheng, X. Liu, J. Qian
DOI: https://doi.org/10.55563/clinexprheumatol/yjsbqm
X. Yang, L. Shi, X. Zheng, X. Liu, J. Qian
DOI: https://doi.org/10.55563/clinexprheumatol/yjsbqm
CER14251
2022,40,1
Pg. 0064-0068
Free to view
Interferon regulatory factor 5 gene variants rs2004640 and rs4728142 are associated with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritis
R. Agca, A.M. Van Sijl, S. Vosslamber, A.E. Voskuyl, C.L. Verweij, M.T. Nurmohamed
DOI: https://doi.org/10.55563/clinexprheumatol/pf511x
R. Agca, A.M. Van Sijl, S. Vosslamber, A.E. Voskuyl, C.L. Verweij, M.T. Nurmohamed
DOI: https://doi.org/10.55563/clinexprheumatol/pf511x
CER14162
2022,40,1
Pg. 0069-0077
Free to view
Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis
J. Tang, J. Lin, Z. Yu, R. Jiang, J. Xia, B. Yang, Q. Ou, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/4me6tg
J. Tang, J. Lin, Z. Yu, R. Jiang, J. Xia, B. Yang, Q. Ou, J. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/4me6tg
CER14004
2022,40,1
Pg. 0078-0085
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica
D. Camellino, F. Paparo, S.D. Morbelli, G. Pesce, M. Bauckneht, M. Bagnasco, M. Cutolo, G. Sambuceti, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/4r78yg
D. Camellino, F. Paparo, S.D. Morbelli, G. Pesce, M. Bauckneht, M. Bagnasco, M. Cutolo, G. Sambuceti, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/4r78yg
CER13899
2022,40,1
Pg. 0086-0096
Free to view
Difficult-to-treat rheumatoid arthritis with respect to responsiveness to biologic/targeted synthetic DMARDs: a retrospective cohort study from the FIRST registry
S. Ochi, F. Mizoguchi, K. Nakano, Y. Tanaka
DOI: https://doi.org/10.55563/clinexprheumatol/g33ia5
S. Ochi, F. Mizoguchi, K. Nakano, Y. Tanaka
DOI: https://doi.org/10.55563/clinexprheumatol/g33ia5
CER14114
2022,40,1
Pg. 0097-0103
Clinical manifestations and outcome of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody positive patients with interstitial lung disease
L. Feng, H. Wang, Y. Zhao, T. Zhao, J. Zhang, F. Huang, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/gtybu5
L. Feng, H. Wang, Y. Zhao, T. Zhao, J. Zhang, F. Huang, J. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/gtybu5
CER14029
2022,40,1
Pg. 0104-0111
Free to view
Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study
M. Merino, Y. Ivanova, T. Martín Lorenzo, Á. Hidalgo-Vega
DOI: https://doi.org/10.55563/clinexprheumatol/mh38sy
M. Merino, Y. Ivanova, T. Martín Lorenzo, Á. Hidalgo-Vega
DOI: https://doi.org/10.55563/clinexprheumatol/mh38sy
CER14203
2022,40,1
Pg. 0112-0119
Free to view
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry
B. Farisoğulları, G.K. Yardımcı, A. Sarı, E. Bilgin, E.Ç. Bölek, E. Duran, L. Kılıç, A. Akdoğan, Ö. Karadağ, Ş. Apraş Bilgen, A.İ. Ertenli, S. Kiraz, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/uxcofr
B. Farisoğulları, G.K. Yardımcı, A. Sarı, E. Bilgin, E.Ç. Bölek, E. Duran, L. Kılıç, A. Akdoğan, Ö. Karadağ, Ş. Apraş Bilgen, A.İ. Ertenli, S. Kiraz, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/uxcofr
CER14110
2022,40,1
Pg. 0120-0128
T cell functions of psoriatic arthritis patients are regulated differently by TNF, IL-17A and IL-6 receptor blockades in vitro
S. Gertel, A. Polachek, V. Furer, D. Levartovsky, H. Sidis, S. Pel, D. Paran, O. Elkayam
DOI: https://doi.org/10.55563/clinexprheumatol/jdhe41
S. Gertel, A. Polachek, V. Furer, D. Levartovsky, H. Sidis, S. Pel, D. Paran, O. Elkayam
DOI: https://doi.org/10.55563/clinexprheumatol/jdhe41
CER14158
2022,40,1
Pg. 0129-0134
Laser speckle contrast analysis in rheumatoid arthritis: a pilot study
M. Vanden Bulcke, A. Vanhaecke, E. Deschepper, M. Cutolo, P. Jacques, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/00egbl
M. Vanden Bulcke, A. Vanhaecke, E. Deschepper, M. Cutolo, P. Jacques, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/00egbl
CER14200
2022,40,1
Pg. 0135-0141
Free to view
Increased interleukin-11 associated with disease activity and development of interstitial lung disease in patients with rheumatoid arthritis
X. Wang, G. Zhu, Q. Ren, J. Wu, B. Gu, D. Su, M. Shen
DOI: https://doi.org/10.55563/clinexprheumatol/mccyj0
X. Wang, G. Zhu, Q. Ren, J. Wu, B. Gu, D. Su, M. Shen
DOI: https://doi.org/10.55563/clinexprheumatol/mccyj0
CER14092
2022,40,1
Pg. 0142-0149
Free to view
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
N. Vegas-Revenga, J.L. Martín-Varillas, V. Calvo-Río, I. González-Mazón, L. Sánchez-Bilbao, E. Beltrán, A. Fonollosa, O. Maíz, A. Blanco, M. Cordero-Coma, N. Ortego, I. Torre, F. Francisco Hernández, S. Muñoz-Fernández, M.M. Esteban Ortega, M. Diaz-Llopis, J. Cañal, J.A. Ventosa, R. Demetrio-Pablo, M. Agudo-Bilbao, L. Domínguez-Casas, J.L. Hernández, S. Castañeda, M.A. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/imrgo2
N. Vegas-Revenga, J.L. Martín-Varillas, V. Calvo-Río, I. González-Mazón, L. Sánchez-Bilbao, E. Beltrán, A. Fonollosa, O. Maíz, A. Blanco, M. Cordero-Coma, N. Ortego, I. Torre, F. Francisco Hernández, S. Muñoz-Fernández, M.M. Esteban Ortega, M. Diaz-Llopis, J. Cañal, J.A. Ventosa, R. Demetrio-Pablo, M. Agudo-Bilbao, L. Domínguez-Casas, J.L. Hernández, S. Castañeda, M.A. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/imrgo2
CER14239
2022,40,1
Pg. 0150-0157
Free to view
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index
J. Avouac, R. Degrave, H. Vergneault, A. Combier, S. Wanono, M. Boisson, C. Frantz, Y. Allanore
DOI: https://doi.org/10.55563/clinexprheumatol/usddjr
J. Avouac, R. Degrave, H. Vergneault, A. Combier, S. Wanono, M. Boisson, C. Frantz, Y. Allanore
DOI: https://doi.org/10.55563/clinexprheumatol/usddjr
Brief Paper
CER14869
2022,40,1
Pg. 0158-0161
Human herpesvirus infections and circulating microvesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus
N.S. Rasmussen, A.H. Draborg, G. Houen, C.T. Nielsen
DOI: https://doi.org/10.55563/clinexprheumatol/s364rt
N.S. Rasmussen, A.H. Draborg, G. Houen, C.T. Nielsen
DOI: https://doi.org/10.55563/clinexprheumatol/s364rt
Reviews
CER13960
2022,40,1
Pg. 0162-0172
Free to view
Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review
K.L. Winthrop, Y. Tanaka, E.B. Lee, J. Wollenhaupt, A. Al Enizi, V.F. Azevedo, J.R. Curtis
DOI: https://doi.org/10.55563/clinexprheumatol/cpu6r9
K.L. Winthrop, Y. Tanaka, E.B. Lee, J. Wollenhaupt, A. Al Enizi, V.F. Azevedo, J.R. Curtis
DOI: https://doi.org/10.55563/clinexprheumatol/cpu6r9
CER14447
2022,40,1
Pg. 0173-0182
Free to view
Osteopontin: another piece in the systemic lupus erythematosus immunopathology puzzle
B.-T. Martín-Márquez, F. Sandoval-García, F.-I. Corona-Meraz, M.-H. Petri, Y.-K. Gutiérrez-Mercado, M. Vázquez-Del mercado
DOI: https://doi.org/10.55563/clinexprheumatol/x2g7rp
B.-T. Martín-Márquez, F. Sandoval-García, F.-I. Corona-Meraz, M.-H. Petri, Y.-K. Gutiérrez-Mercado, M. Vázquez-Del mercado
DOI: https://doi.org/10.55563/clinexprheumatol/x2g7rp
Paediatric Rheumatology
CER14547
2022,40,1
Pg. 0183-0190
Anti-rituximab antibodies affect pharmacokinetics and pharmacodynamics of rituximab in children with immune-mediated diseases
I. Oomen, A. Nassar-Sheikh rashid, A.H. Bouts, S.C. Gouw, T.W. Kuijpers, T. Rispens, A. De Vries, G. Wolbink, J.M. Van Den Berg, D. Schonenberg-Meinema
DOI: https://doi.org/10.55563/clinexprheumatol/ftira8
I. Oomen, A. Nassar-Sheikh rashid, A.H. Bouts, S.C. Gouw, T.W. Kuijpers, T. Rispens, A. De Vries, G. Wolbink, J.M. Van Den Berg, D. Schonenberg-Meinema
DOI: https://doi.org/10.55563/clinexprheumatol/ftira8
Letters to the Editor
CER14553
2022,40,1
Pg. 0191-0192
Free to view
Anakinra-induced psoriasis in a patient with Schnitzler's syndrome
A. Bauer-Alonso, R. Fornons-Servent, C. Llobera-Ris, R.M. Penín-Mosquera, J. Hernández-Rodríguez, I. Figueras-Nart
DOI: https://doi.org/10.55563/clinexprheumatol/mjt9x1
A. Bauer-Alonso, R. Fornons-Servent, C. Llobera-Ris, R.M. Penín-Mosquera, J. Hernández-Rodríguez, I. Figueras-Nart
DOI: https://doi.org/10.55563/clinexprheumatol/mjt9x1
CER14795
2022,40,1
Pg. 0193-0194
Free to view
Clinical implications of fever at diagnosis in polymyalgia rheumatica: an age- and sex-matched case control study of 120 patients
A. Betrains, L. Boeckxstaens, K. Van Laere, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/6z2rdg
A. Betrains, L. Boeckxstaens, K. Van Laere, S. Vanderschueren, D. Blockmans
DOI: https://doi.org/10.55563/clinexprheumatol/6z2rdg
CER14761
2022,40,1
Pg. 0195-0196
Free to view
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis
A.-C. Desbois, C. Marques, L. Lefèvre, S. Barmo, C. Lorenzo, M. Leclercq, G. Leroux, C. Comarmond, C. Chapelon-Abric, F. Domont, M. Vautier, D. Saadoun, P. Cacoub
DOI: https://doi.org/10.55563/clinexprheumatol/b7zd6b
A.-C. Desbois, C. Marques, L. Lefèvre, S. Barmo, C. Lorenzo, M. Leclercq, G. Leroux, C. Comarmond, C. Chapelon-Abric, F. Domont, M. Vautier, D. Saadoun, P. Cacoub
DOI: https://doi.org/10.55563/clinexprheumatol/b7zd6b
CER14913
2022,40,1
Pg. 0197-0198
Free to view
Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis
A.M. Yee
DOI: https://doi.org/10.55563/clinexprheumatol/2hu4yl
A.M. Yee
DOI: https://doi.org/10.55563/clinexprheumatol/2hu4yl
Erratum Corrige
CER15534
2022,40,1
Pg. 0198
Free to view
Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity
S.F. Issa, H.M. Lindegaard, T. Lorenzen, K. Junker, A.F. Christensen, K. Hørslev-Petersen, U. Holmskov, G.L. Sorensen, P. Junker
DOI: https://doi.org/10.55563/clinexprheumatol/ico144
S.F. Issa, H.M. Lindegaard, T. Lorenzen, K. Junker, A.F. Christensen, K. Hørslev-Petersen, U. Holmskov, G.L. Sorensen, P. Junker
DOI: https://doi.org/10.55563/clinexprheumatol/ico144